MELEXIS NV (MELE.BR) Fundamental Analysis & Valuation

EBR:MELE • BE0165385973

Current stock price

50.95 EUR
-2.05 (-3.87%)
Last:

This MELE.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. MELE.BR Profitability Analysis

1.1 Basic Checks

  • In the past year MELE was profitable.
  • MELE had a positive operating cash flow in the past year.
  • Each year in the past 5 years MELE has been profitable.
  • Each year in the past 5 years MELE had a positive operating cash flow.
MELE.BR Yearly Net Income VS EBIT VS OCF VS FCFMELE.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

1.2 Ratios

  • With a decent Return On Assets value of 12.46%, MELE is doing good in the industry, outperforming 67.24% of the companies in the same industry.
  • The Return On Equity of MELE (23.22%) is better than 70.69% of its industry peers.
  • MELE has a Return On Invested Capital of 13.97%. This is in the better half of the industry: MELE outperforms 67.24% of its industry peers.
Industry RankSector Rank
ROA 12.46%
ROE 23.22%
ROIC 13.97%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MELE.BR Yearly ROA, ROE, ROICMELE.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

  • The Profit Margin of MELE (13.40%) is comparable to the rest of the industry.
  • MELE's Profit Margin has been stable in the last couple of years.
  • MELE has a Operating Margin (15.96%) which is comparable to the rest of the industry.
  • In the last couple of years the Operating Margin of MELE has remained more or less at the same level.
  • MELE's Gross Margin of 38.59% is on the low side compared to the rest of the industry. MELE is outperformed by 74.14% of its industry peers.
  • MELE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.96%
PM (TTM) 13.4%
GM 38.59%
OM growth 3Y-16.81%
OM growth 5Y1.3%
PM growth 3Y-17.17%
PM growth 5Y-0.38%
GM growth 3Y-3.44%
GM growth 5Y1.26%
MELE.BR Yearly Profit, Operating, Gross MarginsMELE.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. MELE.BR Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MELE is creating some value.
  • MELE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MELE.BR Yearly Shares OutstandingMELE.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MELE.BR Yearly Total Debt VS Total AssetsMELE.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 5.95 indicates that MELE is not in any danger for bankruptcy at the moment.
  • MELE has a Altman-Z score of 5.95. This is comparable to the rest of the industry: MELE outperforms 55.17% of its industry peers.
  • The Debt to FCF ratio of MELE is 3.32, which is a good value as it means it would take MELE, 3.32 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of MELE (3.32) is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.63 indicates that MELE is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.63, MELE is doing worse than 77.59% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 3.32
Altman-Z 5.95
ROIC/WACC1.19
WACC11.7%
MELE.BR Yearly LT Debt VS Equity VS FCFMELE.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M

2.3 Liquidity

  • MELE has a Current Ratio of 5.46. This indicates that MELE is financially healthy and has no problem in meeting its short term obligations.
  • MELE has a Current ratio of 5.46. This is amongst the best in the industry. MELE outperforms 91.38% of its industry peers.
  • A Quick Ratio of 2.63 indicates that MELE has no problem at all paying its short term obligations.
  • MELE has a Quick ratio of 2.63. This is in the better half of the industry: MELE outperforms 79.31% of its industry peers.
Industry RankSector Rank
Current Ratio 5.46
Quick Ratio 2.63
MELE.BR Yearly Current Assets VS Current LiabilitesMELE.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. MELE.BR Growth Analysis

3.1 Past

  • The earnings per share for MELE have decreased strongly by -34.04% in the last year.
  • MELE shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.29% yearly.
  • The Revenue has decreased by -9.99% in the past year.
  • MELE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.59% yearly.
EPS 1Y (TTM)-34.04%
EPS 3Y-17%
EPS 5Y10.29%
EPS Q2Q%24.44%
Revenue 1Y (TTM)-9.99%
Revenue growth 3Y0.14%
Revenue growth 5Y10.59%
Sales Q2Q%8.66%

3.2 Future

  • The Earnings Per Share is expected to grow by 14.02% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 6.71% on average over the next years.
EPS Next Y9.26%
EPS Next 2Y17.28%
EPS Next 3Y17.58%
EPS Next 5Y14.02%
Revenue Next Year1.53%
Revenue Next 2Y5.11%
Revenue Next 3Y6.15%
Revenue Next 5Y6.71%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MELE.BR Yearly Revenue VS EstimatesMELE.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
MELE.BR Yearly EPS VS EstimatesMELE.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

5

4. MELE.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 18.26, MELE is valued on the expensive side.
  • 86.21% of the companies in the same industry are more expensive than MELE, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 24.88, MELE is valued a bit cheaper.
  • The Price/Forward Earnings ratio is 16.71, which indicates a correct valuation of MELE.
  • Based on the Price/Forward Earnings ratio, MELE is valued cheaper than 86.21% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of MELE to the average of the S&P500 Index (22.19), we can say MELE is valued slightly cheaper.
Industry RankSector Rank
PE 18.26
Fwd PE 16.71
MELE.BR Price Earnings VS Forward Price EarningsMELE.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • MELE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MELE is cheaper than 79.31% of the companies in the same industry.
  • MELE's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MELE is cheaper than 89.66% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.23
EV/EBITDA 12.97
MELE.BR Per share dataMELE.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MELE does not grow enough to justify the current Price/Earnings ratio.
  • MELE's earnings are expected to grow with 17.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.97
PEG (5Y)1.78
EPS Next 2Y17.28%
EPS Next 3Y17.58%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

7

5. MELE.BR Dividend Analysis

5.1 Amount

  • MELE has a Yearly Dividend Yield of 4.89%, which is a nice return.
  • Compared to an average industry Dividend Yield of 0.78, MELE pays a better dividend. On top of this MELE pays more dividend than 98.28% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, MELE pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.89%

5.2 History

  • On average, the dividend of MELE grows each year by 10.98%, which is quite nice.
Dividend Growth(5Y)10.98%
Div Incr Years3
Div Non Decr Years6
MELE.BR Yearly Dividends per shareMELE.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • 131.42% of the earnings are spent on dividend by MELE. This is not a sustainable payout ratio.
  • The dividend of MELE is growing, but earnings are growing more, so the dividend growth is sustainable.
DP131.42%
EPS Next 2Y17.28%
EPS Next 3Y17.58%
MELE.BR Yearly Income VS Free CF VS DividendMELE.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M
MELE.BR Dividend Payout.MELE.BR Dividend Payout, showing the Payout Ratio.MELE.BR Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

MELE.BR Fundamentals: All Metrics, Ratios and Statistics

MELEXIS NV

EBR:MELE (3/27/2026, 7:00:00 PM)

50.95

-2.05 (-3.87%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)02-04
Earnings (Next)04-28
Inst Owners14.8%
Inst Owner ChangeN/A
Ins Owners25%
Ins Owner ChangeN/A
Market Cap2.06B
Revenue(TTM)839.62M
Net Income(TTM)112.51M
Analysts76
Price Target63.91 (25.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.89%
Yearly Dividend3.7
Dividend Growth(5Y)10.98%
DP131.42%
Div Incr Years3
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-13.76%
Min EPS beat(2)-20.2%
Max EPS beat(2)-7.32%
EPS beat(4)1
Avg EPS beat(4)3.1%
Min EPS beat(4)-20.2%
Max EPS beat(4)42.38%
EPS beat(8)2
Avg EPS beat(8)-3.06%
EPS beat(12)5
Avg EPS beat(12)-2.06%
EPS beat(16)8
Avg EPS beat(16)0.6%
Revenue beat(2)0
Avg Revenue beat(2)-2.39%
Min Revenue beat(2)-2.86%
Max Revenue beat(2)-1.91%
Revenue beat(4)1
Avg Revenue beat(4)-0.84%
Min Revenue beat(4)-2.86%
Max Revenue beat(4)3.28%
Revenue beat(8)1
Avg Revenue beat(8)-1.88%
Revenue beat(12)2
Avg Revenue beat(12)-1.62%
Revenue beat(16)5
Avg Revenue beat(16)-1.08%
PT rev (1m)-11.21%
PT rev (3m)-10.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.24%
EPS NY rev (1m)-14.44%
EPS NY rev (3m)-14.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.93%
Revenue NY rev (1m)-6.74%
Revenue NY rev (3m)-6.74%
Valuation
Industry RankSector Rank
PE 18.26
Fwd PE 16.71
P/S 2.45
P/FCF 21.23
P/OCF 16.3
P/B 4.25
P/tB 4.26
EV/EBITDA 12.97
EPS(TTM)2.79
EY5.48%
EPS(NY)3.05
Fwd EY5.98%
FCF(TTM)2.4
FCFY4.71%
OCF(TTM)3.13
OCFY6.14%
SpS20.78
BVpS11.99
TBVpS11.96
PEG (NY)1.97
PEG (5Y)1.78
Graham Number27.44
Profitability
Industry RankSector Rank
ROA 12.46%
ROE 23.22%
ROCE 16.8%
ROIC 13.97%
ROICexc 14.61%
ROICexgc 14.63%
OM 15.96%
PM (TTM) 13.4%
GM 38.59%
FCFM 11.55%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-16.81%
OM growth 5Y1.3%
PM growth 3Y-17.17%
PM growth 5Y-0.38%
GM growth 3Y-3.44%
GM growth 5Y1.26%
F-Score5
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 3.32
Debt/EBITDA 1.64
Cap/Depr 55.05%
Cap/Sales 3.5%
Interest Coverage 14.46
Cash Conversion 67.44%
Profit Quality 86.17%
Current Ratio 5.46
Quick Ratio 2.63
Altman-Z 5.95
F-Score5
WACC11.7%
ROIC/WACC1.19
Cap/Depr(3y)125.38%
Cap/Depr(5y)110.34%
Cap/Sales(3y)6.34%
Cap/Sales(5y)5.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-34.04%
EPS 3Y-17%
EPS 5Y10.29%
EPS Q2Q%24.44%
EPS Next Y9.26%
EPS Next 2Y17.28%
EPS Next 3Y17.58%
EPS Next 5Y14.02%
Revenue 1Y (TTM)-9.99%
Revenue growth 3Y0.14%
Revenue growth 5Y10.59%
Sales Q2Q%8.66%
Revenue Next Year1.53%
Revenue Next 2Y5.11%
Revenue Next 3Y6.15%
Revenue Next 5Y6.71%
EBIT growth 1Y-39.08%
EBIT growth 3Y-16.7%
EBIT growth 5Y12.03%
EBIT Next Year46.76%
EBIT Next 3Y25.95%
EBIT Next 5Y18.48%
FCF growth 1Y-22.5%
FCF growth 3Y-13.14%
FCF growth 5Y6.45%
OCF growth 1Y-29.12%
OCF growth 3Y-12.39%
OCF growth 5Y5.69%

MELEXIS NV / MELE.BR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MELEXIS NV (MELE.BR) stock?

ChartMill assigns a fundamental rating of 5 / 10 to MELE.BR.


What is the valuation status of MELEXIS NV (MELE.BR) stock?

ChartMill assigns a valuation rating of 5 / 10 to MELEXIS NV (MELE.BR). This can be considered as Fairly Valued.


How profitable is MELEXIS NV (MELE.BR) stock?

MELEXIS NV (MELE.BR) has a profitability rating of 5 / 10.


What is the valuation of MELEXIS NV based on its PE and PB ratios?

The Price/Earnings (PE) ratio for MELEXIS NV (MELE.BR) is 18.26 and the Price/Book (PB) ratio is 4.25.


What is the expected EPS growth for MELEXIS NV (MELE.BR) stock?

The Earnings per Share (EPS) of MELEXIS NV (MELE.BR) is expected to grow by 9.26% in the next year.